# US 2016/0355861 A1 · Method for producing gamma-glutamylvalylglycine or a salt thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355861 A1
- Document ID: US20160355861A1
- Status: Published application
- Kind: A1
- Application number: 15/235,311
- Filed: 2016-08-12
- Published: 2016-12-08
- Earliest claimed: 2011-10-07
- Assignees: Ajinomoto Co., Inc.
- Applicants: Ajinomoto Co., Inc.
- Inventors: Hiroyuki NOZAKI; Isao Abe; Jun Takakura; Rie Takeshita; Hideyuki Suzuki; Shunichi Suzuki
- Web page: https://patentgrep.com/patent/US20160355861A1

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K 5/0819: {with the first amino acid being acidic}
- C12N 9/104: {Aminoacyltransferases (2.3.2)}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12Y 203/02002: Gamma-glutamyltransferase (2.3.2.2)
- C07K 5/0215: {containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu}
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

A method for producing γ-Glu-Val-Gly comprising the step of reacting Val-Gly with a γ-glutamyl group donor in the presence of a γ-glutamyltransferase, a microorganism containing the enzyme, or a processed product thereof to generate γ-Glu-Val-Gly, wherein the γ-glutamyltransferase consists of a large subunit and a small subunit, and the small subunit has a specific mutation.

## Claims

### Claim 1

(canceled)

### Claim at position 2

2: A method for producing γ-Glu-Val-Gly, comprising reacting Val-Gly with a γ-glutamyl group donor in the presence of a γ-glutamyltransferase, such that γ-Glu-Val-Gly is generated,
wherein the γ-glutamyltransferase comprises a large subunit and a small subunit,
the small subunit has an amino acid sequence having no less than 90% sequence identity to the amino acid sequence of the positions 391 to 580 of the amino acid sequence of SEQ ID NO: 2, wherein the tyrosine at the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion.

### Claim at position 3 (depends on 2)

3: The method according to claim 2, wherein the tyrosine at the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.

### Claim at position 4 (depends on 2)

4: The method according to claim 2, wherein the small subunit has an amino acid substitution selected from the group consisting of Y444D, Y444E, Y444A, (T413A+Y444E), (T413H+Y444E), (T413N+Y444E), (Q430N+Y444E), (Q430N+Y444D), (Q430N+Y444N), (P441A+Y444E), (V443A+Y444E), (V443E+Y444E), (V443G+Y444E), (V443L+Y444E), (V443N+Y444E), (V443Q+Y444E), (Y444E+L446A), (Y444E+A453S), (Y444E+D472I), (Y444E+G484A), (Y444E+G484S), (Y444E+S498C), (Y444E+Q542H), (Y444E+D561N), (T413N+Y444E+V443A), (T413N+Y444E+A453S), (T413N+Y444E+S498C), (T413N+Y444E+Q542H), (G484S+Y444E+V443A), (G484S+Y444E+Q542H), (Q430N+Y444E+T413N), (T413H+Y444E+G484S), (T413N+Y444E+G484S), (T413N+Y444E+G484S+V443A), (T413N+Y444E+G484S+A453 S), (T413N+Y444E+G484S+Q542H), (T413N+Y444E+G484S+S572K) (T413N+Y444E+G484S+Q430N), and (T413N+Y444E+G484E+S498C), in SEQ ID NO: 2.

### Claim at position 5 (depends on 2)

5: The method according to claim 2, wherein the small subunit has the amino acid sequence of SEQ ID NO: 13 except that the tyrosine at the position 44 of SEQ ID NO: 13 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion.

### Claim at position 6 (depends on 2)

6: The method according to claim 2, wherein the small subunit has the amino acid sequence of
the positions 391 to 580 of SEQ ID NO: 2 except that the tyrosine at the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 391 to 580 of SEQ ID NO: 3 except that the tyrosine at the position 444 of SEQ ID NO: 3 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 392 to 581 of SEQ ID NO: 4 except that the tyrosine at the position 445 of SEQ ID NO: 4 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 388 to 577 of SEQ ID NO: 5 except that the tyrosine at the position 441 of SEQ ID NO: 5 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 391 to 580 of SEQ ID NO: 6 except that the tyrosine at the position 444 of SEQ ID NO: 6 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 391 to 580 of SEQ ID NO: 7 except that the tyrosine at the position 444 of SEQ ID NO: 7 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 391 to 580 of SEQ ID NO: 8 except that the tyrosine at the position 444 of SEQ ID NO: 8 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 400 to 589 of SEQ ID NO: 9 except that the tyrosine at the position 453 of SEQ ID NO: 9 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 391 to 580 of SEQ ID NO: 10 except that the tyrosine at the position 444 of SEQ ID NO: 10 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
the positions 392 to 581 of SEQ ID NO: 11 except that the tyrosine at the position 445 of SEQ ID NO: 11 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine, or
the positions 392 to 581 of SEQ ID NO: 12 except that the tyrosine at the position 445 of SEQ ID NO: 12 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.

### Claim at position 7 (depends on 2)

7: The method according to claim 2, wherein the γ-glutamyl group donor is L-glutamine or a salt thereof.

### Claim at position 8 (depends on 2)

8: The method according to claim 2, wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a microorganism containing the γ-glutamyltransferase, and the microorganism containing the γ-glutamyltransferase is a bacterium belonging to Enterobacteriaceae.

### Claim at position 9 (depends on 8)

9: The method according to claim 8, wherein the microorganism containing the γ-glutamyltransferase is an Escherichia bacterium.

### Claim at position 10 (depends on 9)

10: The method according to claim 9, wherein the microorganism containing the γ-glutamyltransferase is Escherichia coli.

### Claim at position 11 (depends on 8)

11: The method according to claim 8, wherein the microorganism containing the γ-glutamyltransferase is deficient in peptidase D.

### Claim at position 12 (depends on 2)

12: The method according to claim 2, wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a metal chelating agent.

### Claim at position 13 (depends on 2)

13: The method according to claim 2,
wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a microorganism containing the γ-glutamyltransferase or a processed product of the microorganism, and
the processed product of the microorganism has enzymatic activity of the γ-glutamyltransferase and is selected from the group consisting of a disrupted cell of the microorganism, an extract of the microorganism, a partially purified product of the microorganism, a purified product of the γ-glutamyltransferase, an acrylamide- or carrageenan immobilized cell of the microorganism, and the γ-glutamyltransferase immobilized on a solid phase.

### Claim at position 14 (depends on 2)

14: The method according to claim 2, wherein the small subunit has the amino acid sequence of SEQ ID NO: 13 except that the tyrosine at the position 44 of SEQ ID NO: 13 corresponding to the position 444 of SEQ ID NO: 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.

### Claim at position 15 (depends on 2)

15: The method according to claim 2, wherein the small subunit has the amino acid sequence of
the positions 391 to 580 of SEQ ID NO: 3 except that the tyrosine at the position 444 of SEQ ID NO: 3 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 392 to 581 of SEQ ID NO: 4 except that the tyrosine at the position 445 of SEQ ID NO: 4 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 388 to 577 of SEQ ID NO: 5 except that the tyrosine at the position 441 of SEQ ID NO: 5 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 391 to 580 of SEQ ID NO: 6 except that the tyrosine at the position 444 of SEQ ID NO: 6 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 391 to 580 of SEQ ID NO: 7 except that the tyrosine at the position 444 of SEQ ID NO: 7 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 391 to 580 of SEQ ID NO: 8 except that the tyrosine at the position 444 of SEQ ID NO: 8 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 400 to 589 of SEQ ID NO: 9 except that the tyrosine at the position 453 of SEQ ID NO: 9 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 391 to 580 of SEQ ID NO: 10 except that the tyrosine at the position 444 of SEQ ID NO: 10 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion,
the positions 392 to 581 of SEQ ID NO: 11 except that the tyrosine at the position 445 of SEQ ID NO: 11 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion, or
the positions 392 to 581 of SEQ ID NO: 12 except that the tyrosine at the position 445 of SEQ ID NO: 12 corresponding to the position 444 of SEQ ID NO: 2 is modified by substitution, deletion, insertion, addition, or inversion.
